How IRB leaders view and approach challenges raised by industry-funded research
Affiliations
- PMID: 23822047
- PMCID: PMC3792492
Item in Clipboard
How IRB leaders view and approach challenges raised by industry-funded research
IRB.
2013 May-Jun.
No abstract available
Figures
Challenges Posed by Industry-Funded Research and IRB Responses
Similar articles
-
Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.Account Res. 2003 Jul-Sep;10(3):137-58. doi: 10.1080/714906093. Account Res. 2003. PMID: 14979317 No abstract available.
-
Pharma buys a conscience.Am Prospect. 2001 Sep 24-Oct 8;12(17):16-20. Am Prospect. 2001. PMID: 16184653 No abstract available.
-
Independent medical research.Neth J Med. 2007 Apr;65(4):124-6. Neth J Med. 2007. PMID: 17452759 No abstract available.
-
Conflicts of interest in research involving human beings.J Int Bioethique. 2008 Mar-Jun;19(1-2):143-54, 202-3. doi: 10.3917/jib.191.0143. J Int Bioethique. 2008. PMID: 18664007 Review.
-
Industry funding effect on positive results of probiotic use in the management of acute diarrhea: a systematized review.Eur J Gastroenterol Hepatol. 2019 Mar;31(3):289-302. doi: 10.1097/MEG.0000000000001322. Eur J Gastroenterol Hepatol. 2019. PMID: 30557228
Cited by
-
Benchmarks for ethically credible partnerships between industry and academic health centers: beyond disclosure of financial conflicts of interest.Clin Transl Med. 2015 Dec;4(1):36. doi: 10.1186/s40169-015-0077-y. Epub 2015 Dec 14. Clin Transl Med. 2015. PMID: 26668063 Free PMC article.
-
Barriers to Effective Deliberation in Clinical Research Oversight.HEC Forum. 2016 Sep;28(3):245-59. doi: 10.1007/s10730-015-9298-0. HEC Forum. 2016. PMID: 26613717
-
How IRBs view and make decisions about social risks.J Empir Res Hum Res Ethics. 2013 Jul;8(3):58-65. doi: 10.1525/jer.2013.8.3.58. J Empir Res Hum Res Ethics. 2013. PMID: 23933777 Free PMC article.
References
-
- Elliott C. Useless studies, real harm. New York Times. 2011 Jul 28; http://www.nytimes.com/2011/07/29/opinion/useless-pharmaceutical-studies....
-
- Psaty BM, Burke SP. Protecting the health of the public— Institute of Medicine recommendations on drug safety. NEJM. 2006;355 (17):1753–1755. - PubMed
-
- Sox HC, Rennie D. Seeding trials: Just say “no. Annals of Internal Medicine. 2008;149 (4):279–281. - PubMed
-
- Glasser SP, Salas M, Delzell E. Importance and challenges of studying marketed drugs: What is a phase IV study? Journal of Clinical Pharmacology. 2007;47(9):1074–1086. - PubMed
-
-
See ref. , Sox and Rennie 2008 Katz K. Time to nip “seeding trials” in the bud. Archives of Dermatology. 2008;144(3):403–404.Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283(20):2701–2711.
-
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources